SCHEMBL1728323

SCHEMBL1728323

C=CC[C@@](CC(=O)O)(Cc1ccccc1)NC(=O)OC(C)(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
CYP2C19 P33261 2/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
MAPT P10636 1/20 0.44
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA7 P43166 1/20 0.41
CA14 Q9ULX7 1/20 0.41
ATM Q13315 1/20 0.41
AKT1 P31749 3/20 0.40
CTSK P43235 3/20 0.38
IDO1 P14902 1/20 0.38
CTSS P25774 5/20 0.37
CTSL P07711 3/20 0.37
CTSB P07858 3/20 0.37
RECQL P46063 1/20 0.37
HIF1A Q16665 1/20 0.37
PPARA Q07869 2/20 0.37
PPARG P37231 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6063076 1.00 ALDH1A1 (0.48) ALDH1A1CYP2C19CYP3A4CYP2C9MAPT
SCHEMBL6479945 0.87 ALDH1A1 (0.41) ALDH1A1CYP2C19CYP3A4CYP2C9CA12
Bicarbonate SCHEMBL1728324 0.81 ALDH1A1 (0.48) ALDH1A1CYP2C19CYP3A4CYP2C9MAPT
SCHEMBL4399136 0.80 ALDH1A1 (0.47) ALDH1A1CYP2C19CYP3A4CYP2C9MAPT
SCHEMBL4399131 0.80 ALDH1A1 (0.47) ALDH1A1CYP2C19CYP3A4CYP2C9MAPT
SCHEMBL8292151 0.79 CA12 (0.49) ALDH1A1CYP2C19CYP3A4CYP2C9CA12
SCHEMBL9150280 0.79 CYP2C19 (0.45) ALDH1A1CYP2C19CYP3A4CYP2C9CA12
SCHEMBL8225007 0.78 MAPT (0.52) ALDH1A1CYP2C19CYP3A4CYP2C9MAPT
SCHEMBL3787958 0.78 CA12 (0.48) ALDH1A1CYP2C19CYP3A4CYP2C9CA12
SCHEMBL6479942 0.77 MAPT (0.46) ALDH1A1CYP2C19CYP3A4CYP2C9MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1651653-B1 NOVEL CYANO THIAZOLIDES, METHODS FOR THE PRODUCTION THEREOF, AND USE THEREOF AS A MEDICAMENT SANOFI AVENTIS DEUTSCHLAND (DE) 2011-11-23 EP disclosed
EP-1651653-A1 NOVEL CYANO THIAZOLIDES, METHODS FOR THE PRODUCTION THEREOF, AND USE THEREOF AS A MEDICAMENT Sanofi-Aventis Deutschland GmbH (DE) 2006-05-03 EP disclosed
US-7008957-B2 Bicyclic cyanoheterocycles, process for their preparation and their use as medicaments SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2006-03-07 US disclosed
US-20050059716-A1 Novel bicyclic cyanoheterocycles, process for their preparation and their use as medicaments AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2005-03-17 US disclosed
WO-2005012312-A1 NOVEL CYANO THIAZOLIDES, METHODS FOR THE PRODUCTION THEREOF, AND USE THEREOF AS A MEDICAMENT SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2005-02-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050059716-A1 Novel bicyclic cyanoheterocycles, process for their preparation and their use as medicaments CYP11B2, GOT2, CYP11B1 ALDH1A1 1053/4885CYP2C19 277/4885CYP3A4 261/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.